DXSN:F:F-Xtrackers - ShortDAX Daily Swap UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 10.124

Change

0.00 (0.00)%

Market Cap

N/A

Volume

N/A

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-04-02 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
SXR8:F iShares Core S&P 500 UCITS ETF..

-31.10 (-5.63%)

USD 108.00B
UIM5:F UBS (Lux) Fund Solutions - MSC..

-2.73 (-5.44%)

USD 105.67B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

-2.79 (-5.06%)

USD 104.83B
XDNY:F Xtrackers MSCI Japan ESG Scree..

-0.79 (-5.28%)

USD 62.86B
VUSA:F Vanguard Funds Public Limited ..

-5.37 (-5.42%)

USD 51.63B
SXRZ:F iShares VII PLC - iShares Nikk..

-10.40 (-4.67%)

USD 49.04B
XJSE:F Xtrackers II - Japan Governmen..

+0.13 (+1.75%)

USD 41.48B
0ZC:F Zscaler Inc

-11.64 (-6.24%)

USD 37.92B
BSND:F Danone SA

+0.10 (+0.72%)

USD 33.83B
VGWL:F Vanguard FTSE All-World UCITS ..

-5.62 (-4.49%)

USD 24.77B

ETFs Containing DXSN:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -10.85% 11% F 31% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -10.85% 11% F 30% F
Trailing 12 Months  
Capital Gain -13.98% 10% F 34% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -13.98% 9% A- 30% F
Trailing 5 Years  
Capital Gain -59.10% 1% F 8% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return -59.10% 1% F 5% F
Average Annual (5 Year Horizon)  
Capital Gain -9.53% 7% C- 21% F
Dividend Return -9.53% 7% C- 19% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 11.73% 57% F 87% B+
Risk Adjusted Return -81.30% 5% F 10% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.